Ruan Ke-He, Wu Jiaxin, So Shui-Ping, Jenkins Lori A, Ruan Cheng-Huai
Vascular Biology Research Center and Division of Hematology, Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.
Eur J Biochem. 2004 Jul;271(14):3006-16. doi: 10.1111/j.1432-1033.2004.04232.x.
To overcome the difficulty of characterizing the structures of the extracellular loops (eLPs) of G protein-coupled receptors (GPCRs) other than rhodopsin, we have explored a strategy to generate a three-dimensional structural model for a GPCR, the thromboxane A(2) receptor. This three-dimensional structure was completed by the assembly of the NMR structures of the computation-guided constrained peptides that mimicked the extracellular loops and connected to the conserved seven transmembrane domains. The NMR structure-based model reveals the structural features of the eLPs, in which the second extracellular loop (eLP(2)) and the disulfide bond between the first extracellular loop (eLP(1)) and eLP(2) play a major role in forming the ligand recognition pocket. The eLP(2) conformation is dynamic and regulated by the oxidation and reduction of the disulfide bond, which affects ligand docking in the initial recognition. The reduced form of the thromboxane A(2) receptor experienced a decrease in ligand binding activity due to the rearrangement of the eLP(2) conformation. The ligand-bound receptor was, however, resistant to the reduction inactivation because the ligand covered the disulfide bond and stabilized the eLP(2) conformation. This molecular mechanism of ligand recognition is the first that may be applied to other prostanoid receptors and other GPCRs.
为了克服表征除视紫红质以外的G蛋白偶联受体(GPCR)细胞外环(eLP)结构的困难,我们探索了一种为GPCR——血栓素A2受体生成三维结构模型的策略。这个三维结构是通过组装模拟细胞外环并连接到保守的七个跨膜结构域的计算引导约束肽的核磁共振结构而完成的。基于核磁共振结构的模型揭示了eLP的结构特征,其中第二个细胞外环(eLP(2))以及第一个细胞外环(eLP(1))和eLP(2)之间的二硫键在形成配体识别口袋中起主要作用。eLP(2)的构象是动态的,受二硫键氧化还原的调节,这在初始识别中影响配体对接。由于eLP(2)构象的重排,血栓素A2受体的还原形式的配体结合活性降低。然而,配体结合的受体对还原失活具有抗性,因为配体覆盖了二硫键并稳定了eLP(2)构象。这种配体识别的分子机制可能是第一种可应用于其他前列腺素受体和其他GPCR的机制。